News
CHSYF
0.931
NaN%
--
China Medical System Keeps Share Capital and Public Float Stable in April
TipRanks · 6d ago
Guotai Haitong Keeps Their Buy Rating on China Medical System Holdings (CHSYF)
TipRanks · 05/01 00:27
China Medical System’s MG‑K10 Allergy Drug NDA Accepted in China
TipRanks · 04/23 11:41
China Medical System Sets AGM to Approve 2025 Results, Dividend and Share Issuance Mandate
TipRanks · 04/01 13:46
First Shanghai Securities Sticks to Its Buy Rating for China Medical System Holdings (CHSYF)
TipRanks · 03/20 05:37
Guotai Haitong Sticks to Their Buy Rating for China Medical System Holdings (CHSYF)
TipRanks · 03/19 05:25
China Medical System Tightens Nomination Committee Governance Rules
TipRanks · 03/16 23:38
China Medical System Declares Final Dividend for 2025
TipRanks · 03/16 23:08
China Medical System Sets Out Board and Committee Structure
TipRanks · 03/16 23:08
China Medical System Lifts Revenue and Dividend as Innovation and Overseas Push Gather Pace
TipRanks · 03/16 15:11
China Medical System Wins China Approval for New Renal Anaemia Drug
TipRanks · 03/13 11:12
China Medical System Sets March Board Meeting to Approve 2025 Results and Consider Final Dividend
TipRanks · 03/04 11:11
China Medical System Wins NMPA Nod for Novel Obesity Drug Trials
TipRanks · 03/04 11:10
China Medical System Keeps Authorised Share Capital Unchanged in February
TipRanks · 03/02 10:43
China Medical System reports NMPA acceptance of ruxolitinib phosphate cream NDA
TipRanks · 02/24 13:42
China Medical System Wins Priority Review in China for Atopic Dermatitis Use of Ruxolitinib Cream
TipRanks · 02/24 10:07
China Medical System Wins Exclusive China Rights for Lidoderm Pain Patch
TipRanks · 02/12 10:09
China Medical System Wins NMPA Approval to Begin Trials of New Complement Factor B Inhibitor for Kidney Diseases
TipRanks · 02/03 13:07
China Medical System Keeps Authorised Share Capital Unchanged in January
TipRanks · 02/02 10:17
CICC Keeps Their Buy Rating on China Medical System Holdings (CHSYF)
TipRanks · 02/02 07:56
More
Webull provides a variety of real-time CHSYF stock news. You can receive the latest news about China Medical through multiple platforms. This information may help you make smarter investment decisions.
About CHSYF
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.